HEADER RECEPTOR 17-MAR-11 2YCY TITLE TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS AND BOUND TITLE 2 ANTAGONIST CYANOPINDOLOL COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-1 ADRENERGIC RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 33-243,272-276,279-367; COMPND 5 SYNONYM: BETA-1 ADRENORECEPTOR, BETA-1 ADRENOCEPTOR, BETA-T; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: RESIDUES 3-32 AT THE N-TERMINUS AND RESIDUES 244-271 COMPND 9 AND 277-278 OF THE THIRD INTRACELLULAR LOOP WERE DELETED FROM THE COMPND 10 CONSTRUCT. THE CONSTRUCT WAS TRUNCATED AFTER RESIDUE 367 AND A COMPND 11 HEXAHIS TAG ADDED. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MELEAGRIS GALLOPAVO; SOURCE 3 ORGANISM_COMMON: TURKEY; SOURCE 4 ORGANISM_TAXID: 9103; SOURCE 5 CELL: ERYTHROCYTE; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HIGH FIVE; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PBACPAK8 KEYWDS GPCR, RECEPTOR, TRANSDUCER, ANTAGONIST BOUND FORM, INTEGRAL MEMBRANE KEYWDS 2 PROTEIN, G-PROTEIN COUPLED RECEPTOR, THERMOSTABILISING POINT KEYWDS 3 MUTATIONS, SEVEN-HELIX RECEPTOR, 7TM RECEPTOR EXPDTA X-RAY DIFFRACTION AUTHOR R.MOUKHAMETZIANOV,T.WARNE,P.C.EDWARDS,M.J.SERRANO-VEGA,A.G.W.LESLIE, AUTHOR 2 C.G.TATE,G.F.X.SCHERTLER REVDAT 4 20-DEC-23 2YCY 1 HETSYN REVDAT 3 29-JUL-20 2YCY 1 COMPND REMARK HETNAM LINK REVDAT 3 2 1 SITE REVDAT 2 03-APR-19 2YCY 1 SOURCE REVDAT 1 08-JUN-11 2YCY 0 JRNL AUTH R.MOUKHAMETZIANOV,T.WARNE,P.C.EDWARDS,M.J.SERRANO-VEGA, JRNL AUTH 2 A.G.W.LESLIE,C.G.TATE,G.F.X.SCHERTLER JRNL TITL TWO DISTINCT CONFORMATIONS OF HELIX 6 OBSERVED IN JRNL TITL 2 ANTAGONIST-BOUND STRUCTURES OF A {BETA}1- ADRENERGIC JRNL TITL 3 RECEPTOR. JRNL REF PROC.NATL.ACAD.SCI.USA V. 108 8228 2011 JRNL REFN ISSN 0027-8424 JRNL PMID 21540331 JRNL DOI 10.1073/PNAS.1100185108 REMARK 2 REMARK 2 RESOLUTION. 3.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0072 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.51 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 11841 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.255 REMARK 3 R VALUE (WORKING SET) : 0.254 REMARK 3 FREE R VALUE : 0.292 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 601 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.15 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.23 REMARK 3 REFLECTION IN BIN (WORKING SET) : 544 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.3310 REMARK 3 BIN FREE R VALUE SET COUNT : 21 REMARK 3 BIN FREE R VALUE : 0.3590 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4622 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 143 REMARK 3 SOLVENT ATOMS : 3 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 36.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 58.34 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.31000 REMARK 3 B22 (A**2) : -4.23000 REMARK 3 B33 (A**2) : 8.57000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.43000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.593 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.518 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 30.355 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.883 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.843 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4881 ; 0.011 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 3329 ; 0.011 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6638 ; 1.002 ; 1.987 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7906 ; 0.849 ; 3.006 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 576 ; 3.752 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 179 ;25.273 ;21.620 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 808 ;11.999 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 38 ; 8.439 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 797 ; 0.048 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5124 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1060 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2890 ; 1.791 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1158 ; 0.285 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4694 ; 3.335 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1991 ; 4.985 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1944 ; 8.024 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 6 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 55 A 156 1 REMARK 3 1 B 55 B 156 1 REMARK 3 2 A 158 A 173 1 REMARK 3 2 B 158 B 173 1 REMARK 3 3 A 180 A 239 1 REMARK 3 3 B 180 B 239 1 REMARK 3 4 A 242 A 243 1 REMARK 3 4 B 242 B 243 1 REMARK 3 5 A 244 A 248 1 REMARK 3 5 B 244 B 248 1 REMARK 3 6 A 249 A 329 4 REMARK 3 6 B 249 B 329 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 1 A (A): 2427 ; 0.05 ; 0.05 REMARK 3 TIGHT POSITIONAL 1 B (A): 2427 ; 0.05 ; 0.05 REMARK 3 MEDIUM POSITIONAL 1 A (A): 1164 ; 0.04 ; 0.50 REMARK 3 MEDIUM POSITIONAL 1 B (A): 1164 ; 0.04 ; 0.50 REMARK 3 TIGHT THERMAL 1 A (A**2): 2427 ; 0.46 ; 0.50 REMARK 3 TIGHT THERMAL 1 B (A**2): 2427 ; 0.46 ; 0.50 REMARK 3 MEDIUM THERMAL 1 A (A**2): 1164 ; 0.45 ; 2.00 REMARK 3 MEDIUM THERMAL 1 B (A**2): 1164 ; 0.45 ; 2.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES REFINED INDIVIDUALLY REMARK 4 REMARK 4 2YCY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-MAR-11. REMARK 100 THE DEPOSITION ID IS D_1290047602. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JUL-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.980 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12442 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.150 REMARK 200 RESOLUTION RANGE LOW (A) : 47.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 83.0 REMARK 200 DATA REDUNDANCY : 2.500 REMARK 200 R MERGE (I) : 0.14000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.29 REMARK 200 COMPLETENESS FOR SHELL (%) : 53.0 REMARK 200 DATA REDUNDANCY IN SHELL : 1.70 REMARK 200 R MERGE FOR SHELL (I) : 0.35000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2VT4 REMARK 200 REMARK 200 REMARK: DATA WERE COLLECTED IN WEDGES BY SCANNING THE MULTIPLE REMARK 200 SPOTS ON THE CRYSTAL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.47 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.2 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 92.38000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.08050 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 92.38000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 28.08050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ARG 68 TO SER REMARK 400 ENGINEERED RESIDUE IN CHAIN A, MET 90 TO VAL REMARK 400 ENGINEERED RESIDUE IN CHAIN A, CYS 116 TO LEU REMARK 400 ENGINEERED RESIDUE IN CHAIN A, TYR 227 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ALA 282 TO LEU REMARK 400 ENGINEERED RESIDUE IN CHAIN A, PHE 327 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN A, PHE 338 TO MET REMARK 400 ENGINEERED RESIDUE IN CHAIN A, CYS 358 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN B, ARG 68 TO SER REMARK 400 ENGINEERED RESIDUE IN CHAIN B, MET 90 TO VAL REMARK 400 ENGINEERED RESIDUE IN CHAIN B, CYS 116 TO LEU REMARK 400 ENGINEERED RESIDUE IN CHAIN B, TYR 227 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN B, ALA 282 TO LEU REMARK 400 ENGINEERED RESIDUE IN CHAIN B, PHE 327 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN B, PHE 338 TO MET REMARK 400 ENGINEERED RESIDUE IN CHAIN B, CYS 358 TO ALA REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 31 REMARK 465 GLY A 32 REMARK 465 ALA A 33 REMARK 465 GLU A 34 REMARK 465 LEU A 35 REMARK 465 LEU A 36 REMARK 465 SER A 37 REMARK 465 GLN A 38 REMARK 465 GLN A 39 REMARK 465 LYS A 240 REMARK 465 ILE A 241 REMARK 465 PRO A 360 REMARK 465 ARG A 361 REMARK 465 LYS A 362 REMARK 465 ALA A 363 REMARK 465 ASP A 364 REMARK 465 ARG A 365 REMARK 465 ARG A 366 REMARK 465 LEU A 367 REMARK 465 HIS A 368 REMARK 465 HIS A 369 REMARK 465 HIS A 370 REMARK 465 HIS A 371 REMARK 465 HIS A 372 REMARK 465 HIS A 373 REMARK 465 MET B 31 REMARK 465 GLY B 32 REMARK 465 ALA B 33 REMARK 465 GLU B 34 REMARK 465 LEU B 35 REMARK 465 LEU B 36 REMARK 465 SER B 37 REMARK 465 GLN B 38 REMARK 465 PRO B 360 REMARK 465 ARG B 361 REMARK 465 LYS B 362 REMARK 465 ALA B 363 REMARK 465 ASP B 364 REMARK 465 ARG B 365 REMARK 465 ARG B 366 REMARK 465 LEU B 367 REMARK 465 HIS B 368 REMARK 465 HIS B 369 REMARK 465 HIS B 370 REMARK 465 HIS B 371 REMARK 465 HIS B 372 REMARK 465 HIS B 373 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 73 83.07 -65.75 REMARK 500 LEU A 93 -53.80 -129.89 REMARK 500 SER A 145 68.17 -114.18 REMARK 500 SER A 173 -60.44 -120.75 REMARK 500 PHE A 216 -75.74 -108.58 REMARK 500 SER A 273 -174.16 -65.26 REMARK 500 SER B 68 -60.98 -107.63 REMARK 500 GLN B 73 84.59 -68.96 REMARK 500 SER B 145 65.89 -116.09 REMARK 500 PHE B 216 -71.43 -109.53 REMARK 500 ILE B 241 -101.43 -84.94 REMARK 500 ASP B 242 -25.50 64.59 REMARK 500 SER B 273 -174.36 -65.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA B1363 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B 192 O REMARK 620 2 ASP B 195 O 82.5 REMARK 620 3 CYS B 198 O 111.5 94.1 REMARK 620 N 1 2 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1DEP RELATED DB: PDB REMARK 900 MEMBRANE PROTEIN, NMR, 1 STRUCTURE REMARK 900 RELATED ID: 2Y01 RELATED DB: PDB REMARK 900 TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS AND REMARK 900 BOUND PARTIAL AGONIST DOBUTAMINE (CRYSTAL DOB102) REMARK 900 RELATED ID: 2YCX RELATED DB: PDB REMARK 900 TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS AND REMARK 900 BOUND ANTAGONIST CYANOPINDOLOL REMARK 900 RELATED ID: 2VT4 RELATED DB: PDB REMARK 900 TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS AND REMARK 900 BOUND CYANOPINDOLOL REMARK 900 RELATED ID: 2Y04 RELATED DB: PDB REMARK 900 TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS AND REMARK 900 BOUND PARTIAL AGONIST SALBUTAMOL REMARK 900 RELATED ID: 2Y00 RELATED DB: PDB REMARK 900 TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS AND REMARK 900 BOUND PARTIAL AGONIST DOBUTAMINE (CRYSTAL DOB92) REMARK 900 RELATED ID: 2Y03 RELATED DB: PDB REMARK 900 TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS AND REMARK 900 BOUND AGONIST ISOPRENALINE REMARK 900 RELATED ID: 2Y02 RELATED DB: PDB REMARK 900 TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS AND REMARK 900 BOUND AGONIST CARMOTEROL REMARK 900 RELATED ID: 2YCW RELATED DB: PDB REMARK 900 TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS AND REMARK 900 BOUND ANTAGONIST CARAZOLOL REMARK 900 RELATED ID: 2YCZ RELATED DB: PDB REMARK 900 TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS AND REMARK 900 BOUND ANTAGONIST IODOCYANOPINDOLOL REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE FOLLOWING MUTATIONS WERE MADE TO IMPROVE REMARK 999 THERMOSTABILITY R68S,M90V,Y227A,A282L,F327A,F338M THE REMARK 999 FOLLOWING MUTATIONS WERE MADE TO IMPROVE EXPRESSION AND REMARK 999 HELP CRYSTALLISATION C116L, C358A DBREF 2YCY A 33 243 UNP P07700 ADRB1_MELGA 33 243 DBREF 2YCY A 272 276 UNP P07700 ADRB1_MELGA 272 276 DBREF 2YCY A 279 367 UNP P07700 ADRB1_MELGA 279 367 DBREF 2YCY B 33 243 UNP P07700 ADRB1_MELGA 33 243 DBREF 2YCY B 272 276 UNP P07700 ADRB1_MELGA 272 276 DBREF 2YCY B 279 367 UNP P07700 ADRB1_MELGA 279 367 SEQADV 2YCY MET A 31 UNP P07700 EXPRESSION TAG SEQADV 2YCY GLY A 32 UNP P07700 EXPRESSION TAG SEQADV 2YCY SER A 68 UNP P07700 ARG 68 ENGINEERED MUTATION SEQADV 2YCY VAL A 90 UNP P07700 MET 90 ENGINEERED MUTATION SEQADV 2YCY LEU A 116 UNP P07700 CYS 116 ENGINEERED MUTATION SEQADV 2YCY ALA A 227 UNP P07700 TYR 227 ENGINEERED MUTATION SEQADV 2YCY A UNP P07700 CYS 244 DELETION SEQADV 2YCY A UNP P07700 GLU 245 DELETION SEQADV 2YCY A UNP P07700 GLY 246 DELETION SEQADV 2YCY A UNP P07700 ARG 247 DELETION SEQADV 2YCY A UNP P07700 PHE 248 DELETION SEQADV 2YCY A UNP P07700 TYR 249 DELETION SEQADV 2YCY A UNP P07700 GLY 250 DELETION SEQADV 2YCY A UNP P07700 SER 251 DELETION SEQADV 2YCY A UNP P07700 GLN 252 DELETION SEQADV 2YCY A UNP P07700 GLU 253 DELETION SEQADV 2YCY A UNP P07700 GLN 254 DELETION SEQADV 2YCY A UNP P07700 PRO 255 DELETION SEQADV 2YCY A UNP P07700 GLN 256 DELETION SEQADV 2YCY A UNP P07700 PRO 257 DELETION SEQADV 2YCY A UNP P07700 PRO 258 DELETION SEQADV 2YCY A UNP P07700 PRO 259 DELETION SEQADV 2YCY A UNP P07700 LEU 260 DELETION SEQADV 2YCY A UNP P07700 PRO 261 DELETION SEQADV 2YCY A UNP P07700 GLN 262 DELETION SEQADV 2YCY A UNP P07700 HIS 263 DELETION SEQADV 2YCY A UNP P07700 GLN 264 DELETION SEQADV 2YCY A UNP P07700 PRO 265 DELETION SEQADV 2YCY A UNP P07700 ILE 266 DELETION SEQADV 2YCY A UNP P07700 LEU 267 DELETION SEQADV 2YCY A UNP P07700 GLY 268 DELETION SEQADV 2YCY A UNP P07700 ASN 269 DELETION SEQADV 2YCY A UNP P07700 GLY 270 DELETION SEQADV 2YCY A UNP P07700 ARG 271 DELETION SEQADV 2YCY A UNP P07700 THR 277 DELETION SEQADV 2YCY A UNP P07700 SER 278 DELETION SEQADV 2YCY LEU A 282 UNP P07700 ALA 282 ENGINEERED MUTATION SEQADV 2YCY ALA A 327 UNP P07700 PHE 327 ENGINEERED MUTATION SEQADV 2YCY MET A 338 UNP P07700 PHE 338 ENGINEERED MUTATION SEQADV 2YCY ALA A 358 UNP P07700 CYS 358 ENGINEERED MUTATION SEQADV 2YCY HIS A 368 UNP P07700 EXPRESSION TAG SEQADV 2YCY HIS A 369 UNP P07700 EXPRESSION TAG SEQADV 2YCY HIS A 370 UNP P07700 EXPRESSION TAG SEQADV 2YCY HIS A 371 UNP P07700 EXPRESSION TAG SEQADV 2YCY HIS A 372 UNP P07700 EXPRESSION TAG SEQADV 2YCY HIS A 373 UNP P07700 EXPRESSION TAG SEQADV 2YCY MET B 31 UNP P07700 EXPRESSION TAG SEQADV 2YCY GLY B 32 UNP P07700 EXPRESSION TAG SEQADV 2YCY SER B 68 UNP P07700 ARG 68 ENGINEERED MUTATION SEQADV 2YCY VAL B 90 UNP P07700 MET 90 ENGINEERED MUTATION SEQADV 2YCY LEU B 116 UNP P07700 CYS 116 ENGINEERED MUTATION SEQADV 2YCY ALA B 227 UNP P07700 TYR 227 ENGINEERED MUTATION SEQADV 2YCY B UNP P07700 CYS 244 DELETION SEQADV 2YCY B UNP P07700 GLU 245 DELETION SEQADV 2YCY B UNP P07700 GLY 246 DELETION SEQADV 2YCY B UNP P07700 ARG 247 DELETION SEQADV 2YCY B UNP P07700 PHE 248 DELETION SEQADV 2YCY B UNP P07700 TYR 249 DELETION SEQADV 2YCY B UNP P07700 GLY 250 DELETION SEQADV 2YCY B UNP P07700 SER 251 DELETION SEQADV 2YCY B UNP P07700 GLN 252 DELETION SEQADV 2YCY B UNP P07700 GLU 253 DELETION SEQADV 2YCY B UNP P07700 GLN 254 DELETION SEQADV 2YCY B UNP P07700 PRO 255 DELETION SEQADV 2YCY B UNP P07700 GLN 256 DELETION SEQADV 2YCY B UNP P07700 PRO 257 DELETION SEQADV 2YCY B UNP P07700 PRO 258 DELETION SEQADV 2YCY B UNP P07700 PRO 259 DELETION SEQADV 2YCY B UNP P07700 LEU 260 DELETION SEQADV 2YCY B UNP P07700 PRO 261 DELETION SEQADV 2YCY B UNP P07700 GLN 262 DELETION SEQADV 2YCY B UNP P07700 HIS 263 DELETION SEQADV 2YCY B UNP P07700 GLN 264 DELETION SEQADV 2YCY B UNP P07700 PRO 265 DELETION SEQADV 2YCY B UNP P07700 ILE 266 DELETION SEQADV 2YCY B UNP P07700 LEU 267 DELETION SEQADV 2YCY B UNP P07700 GLY 268 DELETION SEQADV 2YCY B UNP P07700 ASN 269 DELETION SEQADV 2YCY B UNP P07700 GLY 270 DELETION SEQADV 2YCY B UNP P07700 ARG 271 DELETION SEQADV 2YCY B UNP P07700 THR 277 DELETION SEQADV 2YCY B UNP P07700 SER 278 DELETION SEQADV 2YCY LEU B 282 UNP P07700 ALA 282 ENGINEERED MUTATION SEQADV 2YCY ALA B 327 UNP P07700 PHE 327 ENGINEERED MUTATION SEQADV 2YCY MET B 338 UNP P07700 PHE 338 ENGINEERED MUTATION SEQADV 2YCY ALA B 358 UNP P07700 CYS 358 ENGINEERED MUTATION SEQADV 2YCY HIS B 368 UNP P07700 EXPRESSION TAG SEQADV 2YCY HIS B 369 UNP P07700 EXPRESSION TAG SEQADV 2YCY HIS B 370 UNP P07700 EXPRESSION TAG SEQADV 2YCY HIS B 371 UNP P07700 EXPRESSION TAG SEQADV 2YCY HIS B 372 UNP P07700 EXPRESSION TAG SEQADV 2YCY HIS B 373 UNP P07700 EXPRESSION TAG SEQRES 1 A 313 MET GLY ALA GLU LEU LEU SER GLN GLN TRP GLU ALA GLY SEQRES 2 A 313 MET SER LEU LEU MET ALA LEU VAL VAL LEU LEU ILE VAL SEQRES 3 A 313 ALA GLY ASN VAL LEU VAL ILE ALA ALA ILE GLY SER THR SEQRES 4 A 313 GLN ARG LEU GLN THR LEU THR ASN LEU PHE ILE THR SER SEQRES 5 A 313 LEU ALA CYS ALA ASP LEU VAL VAL GLY LEU LEU VAL VAL SEQRES 6 A 313 PRO PHE GLY ALA THR LEU VAL VAL ARG GLY THR TRP LEU SEQRES 7 A 313 TRP GLY SER PHE LEU CYS GLU LEU TRP THR SER LEU ASP SEQRES 8 A 313 VAL LEU CYS VAL THR ALA SER ILE GLU THR LEU CYS VAL SEQRES 9 A 313 ILE ALA ILE ASP ARG TYR LEU ALA ILE THR SER PRO PHE SEQRES 10 A 313 ARG TYR GLN SER LEU MET THR ARG ALA ARG ALA LYS VAL SEQRES 11 A 313 ILE ILE CYS THR VAL TRP ALA ILE SER ALA LEU VAL SER SEQRES 12 A 313 PHE LEU PRO ILE MET MET HIS TRP TRP ARG ASP GLU ASP SEQRES 13 A 313 PRO GLN ALA LEU LYS CYS TYR GLN ASP PRO GLY CYS CYS SEQRES 14 A 313 ASP PHE VAL THR ASN ARG ALA TYR ALA ILE ALA SER SER SEQRES 15 A 313 ILE ILE SER PHE TYR ILE PRO LEU LEU ILE MET ILE PHE SEQRES 16 A 313 VAL ALA LEU ARG VAL TYR ARG GLU ALA LYS GLU GLN ILE SEQRES 17 A 313 ARG LYS ILE ASP ARG ALA SER LYS ARG LYS ARG VAL MET SEQRES 18 A 313 LEU MET ARG GLU HIS LYS ALA LEU LYS THR LEU GLY ILE SEQRES 19 A 313 ILE MET GLY VAL PHE THR LEU CYS TRP LEU PRO PHE PHE SEQRES 20 A 313 LEU VAL ASN ILE VAL ASN VAL PHE ASN ARG ASP LEU VAL SEQRES 21 A 313 PRO ASP TRP LEU PHE VAL ALA PHE ASN TRP LEU GLY TYR SEQRES 22 A 313 ALA ASN SER ALA MET ASN PRO ILE ILE TYR CYS ARG SER SEQRES 23 A 313 PRO ASP PHE ARG LYS ALA PHE LYS ARG LEU LEU ALA PHE SEQRES 24 A 313 PRO ARG LYS ALA ASP ARG ARG LEU HIS HIS HIS HIS HIS SEQRES 25 A 313 HIS SEQRES 1 B 313 MET GLY ALA GLU LEU LEU SER GLN GLN TRP GLU ALA GLY SEQRES 2 B 313 MET SER LEU LEU MET ALA LEU VAL VAL LEU LEU ILE VAL SEQRES 3 B 313 ALA GLY ASN VAL LEU VAL ILE ALA ALA ILE GLY SER THR SEQRES 4 B 313 GLN ARG LEU GLN THR LEU THR ASN LEU PHE ILE THR SER SEQRES 5 B 313 LEU ALA CYS ALA ASP LEU VAL VAL GLY LEU LEU VAL VAL SEQRES 6 B 313 PRO PHE GLY ALA THR LEU VAL VAL ARG GLY THR TRP LEU SEQRES 7 B 313 TRP GLY SER PHE LEU CYS GLU LEU TRP THR SER LEU ASP SEQRES 8 B 313 VAL LEU CYS VAL THR ALA SER ILE GLU THR LEU CYS VAL SEQRES 9 B 313 ILE ALA ILE ASP ARG TYR LEU ALA ILE THR SER PRO PHE SEQRES 10 B 313 ARG TYR GLN SER LEU MET THR ARG ALA ARG ALA LYS VAL SEQRES 11 B 313 ILE ILE CYS THR VAL TRP ALA ILE SER ALA LEU VAL SER SEQRES 12 B 313 PHE LEU PRO ILE MET MET HIS TRP TRP ARG ASP GLU ASP SEQRES 13 B 313 PRO GLN ALA LEU LYS CYS TYR GLN ASP PRO GLY CYS CYS SEQRES 14 B 313 ASP PHE VAL THR ASN ARG ALA TYR ALA ILE ALA SER SER SEQRES 15 B 313 ILE ILE SER PHE TYR ILE PRO LEU LEU ILE MET ILE PHE SEQRES 16 B 313 VAL ALA LEU ARG VAL TYR ARG GLU ALA LYS GLU GLN ILE SEQRES 17 B 313 ARG LYS ILE ASP ARG ALA SER LYS ARG LYS ARG VAL MET SEQRES 18 B 313 LEU MET ARG GLU HIS LYS ALA LEU LYS THR LEU GLY ILE SEQRES 19 B 313 ILE MET GLY VAL PHE THR LEU CYS TRP LEU PRO PHE PHE SEQRES 20 B 313 LEU VAL ASN ILE VAL ASN VAL PHE ASN ARG ASP LEU VAL SEQRES 21 B 313 PRO ASP TRP LEU PHE VAL ALA PHE ASN TRP LEU GLY TYR SEQRES 22 B 313 ALA ASN SER ALA MET ASN PRO ILE ILE TYR CYS ARG SER SEQRES 23 B 313 PRO ASP PHE ARG LYS ALA PHE LYS ARG LEU LEU ALA PHE SEQRES 24 B 313 PRO ARG LYS ALA ASP ARG ARG LEU HIS HIS HIS HIS HIS SEQRES 25 B 313 HIS HET P32 A 400 21 HET SOG A1360 20 HET SOG A1361 20 HET P32 B 400 21 HET SOG B1360 20 HET SOG B1361 20 HET SOG B1362 20 HET NA B1363 1 HETNAM P32 4-{[(2S)-3-(TERT-BUTYLAMINO)-2-HYDROXYPROPYL]OXY}-3H- HETNAM 2 P32 INDOLE-2-CARBONITRILE HETNAM SOG OCTYL 1-THIO-BETA-D-GLUCOPYRANOSIDE HETNAM NA SODIUM ION HETSYN SOG 2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5- HETSYN 2 SOG TRIOL; 1-S-OCTYL-BETA-D-THIOGLUCOSIDE; OCTYL 1-THIO- HETSYN 3 SOG BETA-D-GLUCOSIDE; OCTYL 1-THIO-D-GLUCOSIDE; OCTYL 1- HETSYN 4 SOG THIO-GLUCOSIDE FORMUL 3 P32 2(C16 H21 N3 O2) FORMUL 4 SOG 5(C14 H28 O5 S) FORMUL 10 NA NA 1+ FORMUL 11 HOH *3(H2 O) HELIX 1 1 ALA A 42 MET A 48 1 7 HELIX 2 2 LEU A 50 THR A 69 1 20 HELIX 3 3 LEU A 75 LEU A 93 1 19 HELIX 4 4 LEU A 93 GLY A 105 1 13 HELIX 5 5 GLY A 110 SER A 145 1 36 HELIX 6 6 SER A 145 MET A 153 1 9 HELIX 7 7 THR A 154 SER A 173 1 20 HELIX 8 8 SER A 173 MET A 179 1 7 HELIX 9 9 ASP A 186 ASP A 195 1 10 HELIX 10 10 ASN A 204 PHE A 216 1 13 HELIX 11 11 PHE A 216 ILE A 238 1 23 HELIX 12 12 SER A 273 ASN A 316 1 42 HELIX 13 13 PRO A 321 TYR A 343 1 23 HELIX 14 14 SER A 346 LEU A 357 1 12 HELIX 15 15 TRP B 40 THR B 69 1 30 HELIX 16 16 LEU B 75 LEU B 93 1 19 HELIX 17 17 LEU B 93 GLY B 105 1 13 HELIX 18 18 GLY B 110 SER B 145 1 36 HELIX 19 19 SER B 145 MET B 153 1 9 HELIX 20 20 THR B 154 SER B 173 1 20 HELIX 21 21 SER B 173 MET B 179 1 7 HELIX 22 22 ASP B 186 ASP B 195 1 10 HELIX 23 23 ASN B 204 PHE B 216 1 13 HELIX 24 24 PHE B 216 ILE B 238 1 23 HELIX 25 25 SER B 273 ASN B 316 1 42 HELIX 26 26 PRO B 321 TYR B 343 1 23 HELIX 27 27 SER B 346 LEU B 357 1 12 SSBOND 1 CYS A 114 CYS A 199 1555 1555 2.04 SSBOND 2 CYS A 192 CYS A 198 1555 1555 2.13 SSBOND 3 CYS B 114 CYS B 199 1555 1555 2.06 SSBOND 4 CYS B 192 CYS B 198 1555 1555 2.12 LINK O CYS B 192 NA NA B1363 1555 1555 2.52 LINK O ASP B 195 NA NA B1363 1555 1555 2.50 LINK O CYS B 198 NA NA B1363 1555 1555 2.27 CRYST1 184.760 56.161 89.778 90.00 111.27 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005412 0.000000 0.002107 0.00000 SCALE2 0.000000 0.017806 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011953 0.00000